Catheter-based delivery of cells to the heart


Clinical trials have begun to assess the feasibility, safety, and efficacy of administering progenitor cells to the heart in order to repair or perhaps reverse the effects of myocardial ischemia and injury. In contrast to surgical-based injections, which are often coupled with coronary bypass surgery, catheter-based injections are less invasive and make it… (More)
DOI: 10.1038/ncpcardio0446


7 Figures and Tables

Slides referencing similar topics